U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893978) titled 'Placental Organoids Development: Application in the Study of the Human Reproduction Pathophysiology.' on Nov. 20, 2024.
Brief Summary: Placental organoids represent an in vitro 3D reconstruction model of the human placenta and of its complex cellular organization to evaluate the pharmacological effect in terms of placentation, gene expression, protein synthesis and placental secretomics.
Study Start Date: March 15
Study Type: OBSERVATIONAL
Condition:
Preeclampsia
Pregnancy Loss
Preterm Birth
Healthy
Intervention:
DRUG: Placenta organoids treatment
Placenta organoids in vitro treatment with heparin, aspirin, IVIG, filgrastim ...